The goal of the National Programme to Eliminate Lymphatic Filariasis (NPELF) is to eliminate LF by 2015.

The World Health Organization (WHO) is the Secretariat of the Global Programme to Eliminate Lymphatic Filariasis and provides technical and financial support. Detailed information (endemicity, MDA, monitoring and evaluation) on this and other NPELF can be found on www.who.int/lymphatic_filariais.

MDA Treatments

Data not available

Country data

Population	28,000,000
Endemicity	44 of 82 implementation units (IUs) are endemic. Varies from high in east, north and north-west (>30% in 5-18 year olds) to low in most and central Uganda. In some areas where CFA was determined in adults, the prevalence was >50%.
Clinical manifestations	Hydrocoele in males ages >20 years was grom 7 to >28%. Limb elephantiasis ranged from 3.7 to 9.7%.
Drug regime	Albendazole – donated by GlaxoSmithKline Mectizan® - donated by Merck & Co. Inc.
MDA implementation cycle	April/October
Treatment strategy	Door-todoor, kiosks, schools
Social mobilisation	Using radio, print media, school assemblies, IEC material and community mobilisation meetings
Vector control	Combining malaria vector control with LF vector control.
Co-implementation	Onchocerciasis, soil-transmitted helminths, malaria and trachoma (starting in 2007) to be integrated during child health days.

Recognition

Filaria species
	Wuchereria bancrofti		Onchocerca volvulus		Loa loa		Mansonella perstans
Vectors
	Anopheles gambiae complex		Simulium damnosum sl		Culex quinquefasciatus		Culicoides spp.
	An. funestus		S. naevis
Diagnostics
	ICT		Blood slide		Skin snips		Blood smears; Mazotti reaction
	Night blood smears		REMO		Skin biopsies		Counting Chamber

Capacity Building

Year	Type of training	Cadre	Number trained
2005	Training, supervision	Trainers (training of trainers)	350
	Supervision, training lower cadres	Supervisors	1200
	Providing drugs to, and treating, pupils	Teachers	2500
	Drug distribution	Community drug distributors	8000

Programme Support & Partnerships
The NPELF is included in both the national and district (IU) level budgets

Partners	Activities
	Mapping	MDA	Social Mobilisation	Morbidity Management	Hydrocoele Surgery	Operational Research	Training	M&E Surveillance	Funding partners
World Health Organization
Mectizan Donation Program
USAID (from 2007)
GlaxoSmithKline
DANIDA

Disability prevention programme
Disability management was piloted in one sub-country in the Amuria and Katakwi districts with funding from DANID. This has now ended but the demand for hydrocelectomy and lymphoedema management is very high. The work will continue on receipt of €30,000 from an anonymous donor.

Budget line
There is a small budget at the National Level. Some districts have budget lines for LF.